These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20965008)

  • 1. [Nonalcoholic fatty liver disease and psoriasis].
    Rivera R; Vanaclocha F
    Actas Dermosifiliogr; 2010 Oct; 101(8):657-8. PubMed ID: 20965008
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasis and Nonalcoholic Fatty Liver Disease.
    Carrascosa JM; Bonanad C; Dauden E; Botella R; Olveira-Martín A;
    Actas Dermosifiliogr; 2017; 108(6):506-514. PubMed ID: 28318525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis: comorbidities and associations.
    Farley E; Menter A
    G Ital Dermatol Venereol; 2011 Feb; 146(1):9-15. PubMed ID: 21317853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis as the marker of underlying systemic disease.
    Kourosh AS; Miner A; Menter A
    Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new view of psoriasis].
    Jullien D; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):3-7. PubMed ID: 20510168
    [No Abstract]   [Full Text] [Related]  

  • 8. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of non-alcoholic fatty liver disease on cardiovascular disease].
    Ampuero J; Romero-Gómez M
    Gastroenterol Hepatol; 2012 Oct; 35(8):585-93. PubMed ID: 22541252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis, the liver, and the gastrointestinal tract.
    Gisondi P; Del Giglio M; Cozzi A; Girolomoni G
    Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
    van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
    J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis and cardiovascular disorders.
    Ryan C; Menter A
    G Ital Dermatol Venereol; 2012 Apr; 147(2):179-87. PubMed ID: 22481581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-alcoholic fatty liver: position document of the Catalan Society of Gastroenterology].
    Caballería L; Saló J; Berzigotti A; Planas R; Vila C; Huertas C; Torres M; Torán P; Caballería J;
    Gastroenterol Hepatol; 2014; 37(6):372-83. PubMed ID: 24746904
    [No Abstract]   [Full Text] [Related]  

  • 14. [Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis].
    Fraenkel E; Takács R; Hamvas J; Lengyel G; Fehér J
    Orv Hetil; 2007 Apr; 148(17):793-8. PubMed ID: 17452309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Obesity in childhood].
    Shcherbakova MIu; Poriagina GI; Kovaleva EA
    Eksp Klin Gastroenterol; 2010; (7):74-83. PubMed ID: 21033087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities in psoriasis.
    Aurangabadkar SJ
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S10-7. PubMed ID: 23974690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis and metabolic syndrome.
    Takahashi H; Iizuka H
    J Dermatol; 2012 Mar; 39(3):212-8. PubMed ID: 22035413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences.
    Del Ben M; Baratta F; Polimeni L; Angelico F
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S291-6. PubMed ID: 23073870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and non-alcoholic fatty liver disease.
    Wenk KS; Arrington KC; Ehrlich A
    J Eur Acad Dermatol Venereol; 2011 Apr; 25(4):383-91. PubMed ID: 20840346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comorbidity in psoriasis].
    Gerdes S; Mrowietz U; Boehncke WH
    Hautarzt; 2016 Jun; 67(6):438-44. PubMed ID: 27221798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.